NAUT Competitors & Alternatives
Compare Nautilus Biotechnology Inc with similar stocks in the same industry
Biotechnology
NAUT
Main Stock$2.44
Tradestie Score
43
Market Cap
$105.49M
Analyst Upside
+63.9%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANNX
Annexon, Inc. Common Stock
|
$4.20
|
$332.96M | - | 44 | Compare |
|
REPL
Replimune Group, Inc.
|
$22.21
|
$328.62M | - | 34 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.32
|
$304.12M | - | 45 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$16.55
|
$297.23M | - | 33 | Compare |
|
QSI
Quantum-Si Incorporated Class A Common Stock
|
$1.26
|
$295.64M | - | 37 | Compare |
|
OMER
Omeros Corporation
|
$18.05
|
$281.75M | 14.4 | 64 | Compare |
|
DBVT
DBV Technologies S.A.
|
$11.87
|
$275.54M | - | 29 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$20.07
|
$269.08M | 0.1 | 51 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$25.42
|
$256.54M | - | 32 | Compare |
More NAUT Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 3826)
222 stocks in this industry